Martingale Asset Management’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $800K | Buy |
151,487
+39,503
| +35% | +$253K | 0.02% | 576 |
|
|
2026
Q1 | $815K | Buy |
111,984
+16,125
| +17% | +$146K | 0.02% | 546 |
|
|
2025
Q4 | $922K | Sell |
95,859
-19,055
| -17% | -$197K | 0.02% | 490 |
|
|
2025
Q3 | $1.4M | Sell |
114,914
-22,707
| -16% | -$238K | 0.04% | 406 |
|
|
2025
Q2 | $1.1M | Buy |
137,621
+31,434
| +30% | +$221K | 0.03% | 450 |
|
|
2025
Q1 | $771K | Buy |
106,187
+10,443
| +11% | +$75.9K | 0.02% | 520 |
|
|
2024
Q4 | $660K | Buy |
95,744
+61,744
| +182% | +$425K | 0.02% | 561 |
|
|
2024
Q3 | $251K | Buy |
+34,000
| New | +$318K | 0.01% | 736 |
|
|
2021
Q4 | – | Sell |
-48,366
| Closed | -$1.96M | – | 870 |
|
|
2021
Q3 | $1.96M | Buy |
48,366
+19,733
| +69% | +$998K | 0.03% | 312 |
|
|
2021
Q2 | $1.62M | Buy |
28,633
+1
| +0% | +$57 | 0.02% | 287 |
|
|
2021
Q1 | $1.51M | Buy |
+28,632
| New | +$1.56M | 0.02% | 330 |
|
|
2020
Q1 | – | Sell |
-30,807
| Closed | -$1.26M | – | 1009 |
|
|
2019
Q4 | $1.26M | Sell |
30,807
-75,777
| -71% | -$3.09M | 0.01% | 714 |
|
|
2019
Q3 | $4.53M | Sell |
106,584
-54,533
| -34% | -$2.29M | 0.05% | 407 |
|
|
2019
Q2 | $7.95M | Sell |
161,117
-62,152
| -28% | -$3.16M | 0.08% | 265 |
|
|
2019
Q1 | $10.7M | Buy |
223,269
+49,237
| +28% | +$2.98M | 0.12% | 198 |
|
|
2018
Q4 | $10.7M | Buy |
174,032
+15,927
| +10% | +$1.07M | 0.14% | 169 |
|
|
2018
Q3 | $13M | Buy |
158,105
+15,450
| +11% | +$1.23M | 0.15% | 167 |
|
|
2018
Q2 | $11.2M | Buy |
142,655
+3,542
| +3% | +$274K | 0.14% | 178 |
|
|
2018
Q1 | $10.3M | Buy |
139,113
+37,903
| +37% | +$2.69M | 0.13% | 185 |
|
|
2017
Q4 | $6.91M | Sell |
101,210
-430
| -0.4% | -$27.8K | 0.09% | 217 |
|
|
2017
Q3 | $6.25M | Buy |
101,640
+697
| +0.7% | +$42.8K | 0.08% | 250 |
|
|
2017
Q2 | $6.34M | Buy |
100,943
+20,102
| +25% | +$1.15M | 0.09% | 234 |
|
|
2017
Q1 | $4.49M | Sell |
80,841
-44,389
| -35% | -$2.29M | 0.06% | 319 |
|
|
2016
Q4 | $5.98M | Sell |
125,230
-12,547
| -9% | -$703K | 0.08% | 263 |
|
|
2016
Q3 | $8.93M | Buy |
137,777
+124,152
| +911% | +$6.98M | 0.13% | 192 |
|
|
2016
Q2 | $630K | Buy |
13,625
+6,315
| +86% | +$254K | 0.01% | 622 |
|
|
2016
Q1 | $280K | Buy |
7,310
+6
| +0.1% | +$198 | 0.01% | 751 |
|
|
2015
Q4 | $277K | Buy |
+7,304
| New | +$269K | 0.01% | 760 |
|
|
2013
Q3 | – | Sell |
-143,598
| Closed | -$8.78M | – | 1030 |
|
|
2013
Q2 | $8.78M | Buy |
+143,598
| New | +$7.97M | 0.32% | 73 |
|
Other funds holding NUS
CAS
PGCM
Martingale Asset Management's NUS Position: Q2 2026 in Review
Martingale Asset Management increased its Nu Skin (NUS) stake by 35% in Q2 2026, buying an estimated $253K and bringing the position to 151,487 shares worth $800K. The position accounts for 0.02% of the portfolio, ranked #576.
Martingale Asset Management first reported a position in NUS in Q2 2013 and has held it in 29 quarters since. The position peaked at $13M in Q3 2018. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.
- Martingale Asset Management held 151,487 shares of Nu Skin worth $800K as of Q2 2026.
- Martingale Asset Management bought 39,503 Nu Skin shares in Q2 2026, an estimated $253K.
- Nu Skin made up 0.02% of Martingale Asset Management's portfolio in Q2 2026, its #576 holding.
- Martingale Asset Management first reported a position in Nu Skin in Q2 2013 and has held it in 29 quarters since.
- Martingale Asset Management's Nu Skin position peaked at $13M in Q3 2018.
- 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.
Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.